Gut Microbiota Characterization in Patients with Asymptomatic Hyperuricemia: probiotics increased

Asymptomatic hyperuricemia (AH) is an early stage of gout. Emerging evidence shows that the intestinal microbiota is related to gout. However, the relationship between AH and the intestinal microbiota is poorly understood. Therefore, the aim of the current study was to explore the possible correlati...

Full description

Saved in:
Bibliographic Details
Published inBioengineered Vol. 12; no. 1; pp. 7263 - 7275
Main Authors Yang, Hai-Tao, Xiu, Wen-Juan, Liu, Jing-Kun, Yang, Yi, Hou, Xian-Geng, Zheng, Ying-Ying, Wu, Ting-Ting, Wu, Chen-Xin, Xie, Xiang
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 01.01.2021
Subjects
Online AccessGet full text
ISSN2165-5979
2165-5987
2165-5987
DOI10.1080/21655979.2021.1976897

Cover

Abstract Asymptomatic hyperuricemia (AH) is an early stage of gout. Emerging evidence shows that the intestinal microbiota is related to gout. However, the relationship between AH and the intestinal microbiota is poorly understood. Therefore, the aim of the current study was to explore the possible correlation between AH and intestinal flora. We compared the intestinal microbial communities of AH (45 cases) and healthy subjects (45 cases) by 16S rRNA gene sequencing and clustering analysis on the incorporated population. Intestinal-type clustering can be divided into two groups, and significant differences in the proportion of AH are found among different bowel types. Alpha diversity indices were higher in the AH group than in the control group, and beta diversity indices also showed significant differences. A total of 19 genera were found different between the AH group and the control group. Compared with the control group, some probiotics are increased in the AH population. Two groups were ranked by importance of bacteria. We found the different bacteria partially coincided with the important bacteria, and the joint diagnosis level of the important bacteria was good. Conclusion: There were significant differences in the composition of intestinal biota between AH patients and healthy subjects. Some probiotics increased in AH.
AbstractList Asymptomatic hyperuricemia (AH) is an early stage of gout. Emerging evidence shows that the intestinal microbiota is related to gout. However, the relationship between AH and the intestinal microbiota is poorly understood. Therefore, the aim of the current study was to explore the possible correlation between AH and intestinal flora. We compared the intestinal microbial communities of AH (45 cases) and healthy subjects (45 cases) by 16S rRNA gene sequencing and clustering analysis on the incorporated population. Intestinal-type clustering can be divided into two groups, and significant differences in the proportion of AH are found among different bowel types. Alpha diversity indices were higher in the AH group than in the control group, and beta diversity indices also showed significant differences. A total of 19 genera were found different between the AH group and the control group. Compared with the control group, some probiotics are increased in the AH population. Two groups were ranked by importance of bacteria. We found the different bacteria partially coincided with the important bacteria, and the joint diagnosis level of the important bacteria was good. Conclusion: There were significant differences in the composition of intestinal biota between AH patients and healthy subjects. Some probiotics increased in AH.Asymptomatic hyperuricemia (AH) is an early stage of gout. Emerging evidence shows that the intestinal microbiota is related to gout. However, the relationship between AH and the intestinal microbiota is poorly understood. Therefore, the aim of the current study was to explore the possible correlation between AH and intestinal flora. We compared the intestinal microbial communities of AH (45 cases) and healthy subjects (45 cases) by 16S rRNA gene sequencing and clustering analysis on the incorporated population. Intestinal-type clustering can be divided into two groups, and significant differences in the proportion of AH are found among different bowel types. Alpha diversity indices were higher in the AH group than in the control group, and beta diversity indices also showed significant differences. A total of 19 genera were found different between the AH group and the control group. Compared with the control group, some probiotics are increased in the AH population. Two groups were ranked by importance of bacteria. We found the different bacteria partially coincided with the important bacteria, and the joint diagnosis level of the important bacteria was good. Conclusion: There were significant differences in the composition of intestinal biota between AH patients and healthy subjects. Some probiotics increased in AH.
Asymptomatic hyperuricemia (AH) is an early stage of gout. Emerging evidence shows that the intestinal microbiota is related to gout. However, the relationship between AH and the intestinal microbiota is poorly understood. Therefore, the aim of the current study was to explore the possible correlation between AH and intestinal flora. We compared the intestinal microbial communities of AH (45 cases) and healthy subjects (45 cases) by 16S rRNA gene sequencing and clustering analysis on the incorporated population. Intestinal-type clustering can be divided into two groups, and significant differences in the proportion of AH are found among different bowel types. Alpha diversity indices were higher in the AH group than in the control group, and beta diversity indices also showed significant differences. A total of 19 genera were found different between the AH group and the control group. Compared with the control group, some probiotics are increased in the AH population. Two groups were ranked by importance of bacteria. We found the different bacteria partially coincided with the important bacteria, and the joint diagnosis level of the important bacteria was good. Conclusion: There were significant differences in the composition of intestinal biota between AH patients and healthy subjects. Some probiotics increased in AH.
Author Zheng, Ying-Ying
Xiu, Wen-Juan
Wu, Chen-Xin
Hou, Xian-Geng
Liu, Jing-Kun
Yang, Hai-Tao
Wu, Ting-Ting
Xie, Xiang
Yang, Yi
Author_xml – sequence: 1
  givenname: Hai-Tao
  surname: Yang
  fullname: Yang, Hai-Tao
  organization: First Affiliated Hospital of Xinjiang Medical University
– sequence: 2
  givenname: Wen-Juan
  surname: Xiu
  fullname: Xiu, Wen-Juan
  organization: First Affiliated Hospital of Xinjiang Medical University
– sequence: 3
  givenname: Jing-Kun
  surname: Liu
  fullname: Liu, Jing-Kun
  organization: First Affiliated Hospital of Xinjiang Medical University
– sequence: 4
  givenname: Yi
  surname: Yang
  fullname: Yang, Yi
  organization: First Affiliated Hospital of Xinjiang Medical University
– sequence: 5
  givenname: Xian-Geng
  surname: Hou
  fullname: Hou, Xian-Geng
  organization: First Affiliated Hospital of Xinjiang Medical University
– sequence: 6
  givenname: Ying-Ying
  surname: Zheng
  fullname: Zheng, Ying-Ying
  organization: First Affiliated Hospital of Zhengzhou University, Key Laboratory of Cardiac Injury and Repair of Henan Province
– sequence: 7
  givenname: Ting-Ting
  surname: Wu
  fullname: Wu, Ting-Ting
  organization: First Affiliated Hospital of Xinjiang Medical University
– sequence: 8
  givenname: Chen-Xin
  surname: Wu
  fullname: Wu, Chen-Xin
  organization: First Affiliated Hospital of Xinjiang Medical University
– sequence: 9
  givenname: Xiang
  surname: Xie
  fullname: Xie, Xiang
  email: xiangxie999@sina.com
  organization: First Affiliated Hospital of Xinjiang Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34590550$$D View this record in MEDLINE/PubMed
BookMark eNqFUU1v1DAQtVARLaU_AZQjl13s-CMOSKjVClqkIjj0bs06E9YosYPtUC2_Hi-7WwEHOFgzmpn3nvXeU3Lig0dCnjO6ZFTTVzVTUrZNu6xpzZasbZRum0fkbDdfyFY3Jw99056Si5S-UkoZ5UI2-gk5LbWlUtIzAtdzrj46G8PahQzVagMRbMbofkB2wVfOV59Lhz6n6t7lTXWVtuOUw1iGtrrZThjn6CyODl5X057G2VRwNiIk7J6Rxz0MCS8O9ZzcvX93t7pZ3H66_rC6ul1YoXRe9MC17QRowRRvqGx7hLVCoQBVp2TZ1tiupaqVkJpCZzlHhVILIcpDfk7e7mmneT1iZ8uHIwxmim6EuDUBnPlz493GfAnfjdZUKS4LwcsDQQzfZkzZjC5ZHAbwGOZk6mIdk0xqXk5f_K71IHK0tRy82R8UX1OK2Bvr8i8_i7QbDKNml6M55mh2OZpDjgUt_0IfBf6Hu9zjnO9DHOE-xKEzGbZDiH0Eb10y_N8UPwER5LZ-
CitedBy_id crossref_primary_10_2147_DMSO_S429068
crossref_primary_10_3390_microorganisms12040637
crossref_primary_10_3389_fcimb_2022_1051682
crossref_primary_10_1016_j_phymed_2025_156402
crossref_primary_10_1080_21655979_2022_2049959
crossref_primary_10_1080_0886022X_2024_2387429
crossref_primary_10_1016_j_jff_2023_105903
crossref_primary_10_4251_wjgo_v16_i8_3600
crossref_primary_10_1039_D4FO00118D
crossref_primary_10_3389_fmicb_2023_1211831
crossref_primary_10_4236_jbm_2022_1011010
crossref_primary_10_3390_gucdd3010001
crossref_primary_10_1016_j_fbio_2023_102912
crossref_primary_10_3389_fcimb_2022_935723
crossref_primary_10_1038_s41598_024_60427_6
crossref_primary_10_7717_peerj_14554
crossref_primary_10_1016_j_heliyon_2023_e20328
crossref_primary_10_1007_s10067_022_06392_9
crossref_primary_10_1080_10408398_2025_2475238
crossref_primary_10_1016_j_ijbiomac_2024_135666
crossref_primary_10_1080_21655979_2021_2019174
crossref_primary_10_3389_fcimb_2024_1341953
crossref_primary_10_1016_j_foodchem_2024_139444
crossref_primary_10_3389_fmed_2023_1163778
crossref_primary_10_3389_frmbi_2024_1384703
crossref_primary_10_1080_21655979_2021_2009752
crossref_primary_10_3389_fnut_2023_1094483
crossref_primary_10_1016_j_jep_2023_116805
Cites_doi 10.1080/19490976.2020.1748258
10.3389/fmicb.2021.631140
10.1186/s10020-021-00311-5
10.1136/annrheumdis-2021-220439
10.1016/j.numecd.2021.01.003
10.1007/s00394-020-02414-x
10.4082/kjfm.2013.34.4.250
10.1002/art.41614
10.1186/s12866-021-02125-1
10.1186/s40168-019-0683-9
10.1016/j.biopha.2020.110719
10.1038/nature09944
10.1136/bcr-2019-230432
10.3390/nu13031008
10.1007/s40618-021-01513-8
10.1186/s12889-021-10858-x
10.1161/JAHA.120.020180
10.1161/CIRCULATIONAHA.118.033714
10.3390/nu12123835
10.1093/ajcn/nqaa350
10.3390/biomedicines8120598
10.1038/srep20602
10.1136/annrheumdis-2019-215933
10.3390/nu13072125
10.1111/1751-7915.13769
10.1080/21655979.2021.1933840
10.3389/fphys.2020.524236
10.1371/journal.pone.0230895
10.1016/j.apsb.2019.10.007
ContentType Journal Article
Copyright 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021
2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 The Author(s)
Copyright_xml – notice: 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021
– notice: 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 The Author(s)
DBID 0YH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1080/21655979.2021.1976897
DatabaseName Taylor & Francis Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 0YH
  name: Taylor & Francis Open Access
  url: https://www.tandfonline.com
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
DocumentTitleAlternate H.-T. YANG ET AL
EISSN 2165-5987
EndPage 7275
ExternalDocumentID PMC8806635
34590550
10_1080_21655979_2021_1976897
1976897
Genre Research Article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 81770235
GroupedDBID 0YH
4.4
53G
ABCCY
ABPEM
ACGFS
ADBBV
ADCVX
AENEX
AIJEM
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
DGEBU
EBS
EMOBN
GTTXZ
H13
IPNFZ
M4Z
OK1
RIG
RPM
SV3
TDBHL
TFL
TFW
AAYXX
CITATION
EJD
HYE
OVD
TEORI
TTHFI
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c468t-fa38cd4a841637059feab6e46ae6d65a382e9b56264580adc33e6e58444844e3
IEDL.DBID 0YH
ISSN 2165-5979
2165-5987
IngestDate Thu Aug 21 14:11:26 EDT 2025
Fri Jul 11 05:21:23 EDT 2025
Thu Apr 03 06:58:46 EDT 2025
Thu Jul 10 08:13:31 EDT 2025
Thu Apr 24 23:07:56 EDT 2025
Thu Jul 03 04:11:19 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Asymptomatic hyperuricemia
diagnostic model
16s rRNA gene
gut microbiota
probiotics
Language English
License open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c468t-fa38cd4a841637059feab6e46ae6d65a382e9b56264580adc33e6e58444844e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Hai-Tao Yang and Wen-Juan Xiu contributed equally to this article.
OpenAccessLink https://www.tandfonline.com/doi/abs/10.1080/21655979.2021.1976897
PMID 34590550
PQID 2578151583
PQPubID 23479
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8806635
informaworld_taylorfrancis_310_1080_21655979_2021_1976897
proquest_miscellaneous_2578151583
crossref_citationtrail_10_1080_21655979_2021_1976897
crossref_primary_10_1080_21655979_2021_1976897
pubmed_primary_34590550
PublicationCentury 2000
PublicationDate 2021-01-01
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – month: 01
  year: 2021
  text: 2021-01-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Bioengineered
PublicationTitleAlternate Bioengineered
PublicationYear 2021
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References e_1_3_2_27_1
e_1_3_2_28_1
e_1_3_2_29_1
e_1_3_2_20_1
e_1_3_2_21_1
e_1_3_2_22_1
e_1_3_2_23_1
e_1_3_2_24_1
e_1_3_2_25_1
e_1_3_2_26_1
Wang L (e_1_3_2_31_1) 2017; 37
e_1_3_2_16_1
e_1_3_2_9_1
e_1_3_2_17_1
e_1_3_2_8_1
e_1_3_2_18_1
e_1_3_2_7_1
e_1_3_2_19_1
e_1_3_2_2_1
e_1_3_2_30_1
e_1_3_2_10_1
e_1_3_2_11_1
e_1_3_2_32_1
e_1_3_2_6_1
e_1_3_2_12_1
e_1_3_2_5_1
e_1_3_2_4_1
e_1_3_2_14_1
e_1_3_2_3_1
e_1_3_2_15_1
Li P (e_1_3_2_13_1) 2018; 2018
References_xml – ident: e_1_3_2_19_1
  doi: 10.1080/19490976.2020.1748258
– ident: e_1_3_2_27_1
  doi: 10.3389/fmicb.2021.631140
– volume: 37
  start-page: 678
  issue: 5
  year: 2017
  ident: e_1_3_2_31_1
  article-title: [Effects of Clostridium butyricum on serum uric acid and inflammatory mediators in rats with hyperuricemia]
  publication-title: Nan Fang Yi Ke Da Xue Xue Bao
– ident: e_1_3_2_25_1
  doi: 10.1186/s10020-021-00311-5
– ident: e_1_3_2_2_1
  doi: 10.1136/annrheumdis-2021-220439
– ident: e_1_3_2_4_1
  doi: 10.1016/j.numecd.2021.01.003
– ident: e_1_3_2_9_1
  doi: 10.1007/s00394-020-02414-x
– ident: e_1_3_2_11_1
  doi: 10.4082/kjfm.2013.34.4.250
– ident: e_1_3_2_8_1
  doi: 10.1002/art.41614
– ident: e_1_3_2_20_1
  doi: 10.1186/s12866-021-02125-1
– ident: e_1_3_2_12_1
  doi: 10.1186/s40168-019-0683-9
– ident: e_1_3_2_29_1
  doi: 10.1016/j.biopha.2020.110719
– ident: e_1_3_2_14_1
  doi: 10.1038/nature09944
– ident: e_1_3_2_32_1
  doi: 10.1136/bcr-2019-230432
– ident: e_1_3_2_22_1
  doi: 10.3390/nu13031008
– ident: e_1_3_2_3_1
  doi: 10.1007/s40618-021-01513-8
– ident: e_1_3_2_5_1
  doi: 10.1186/s12889-021-10858-x
– ident: e_1_3_2_6_1
  doi: 10.1161/JAHA.120.020180
– ident: e_1_3_2_18_1
  doi: 10.1161/CIRCULATIONAHA.118.033714
– ident: e_1_3_2_7_1
  doi: 10.3390/nu12123835
– ident: e_1_3_2_28_1
  doi: 10.1093/ajcn/nqaa350
– ident: e_1_3_2_30_1
  doi: 10.3390/biomedicines8120598
– ident: e_1_3_2_24_1
  doi: 10.1038/srep20602
– volume: 2018
  start-page: 3623274
  year: 2018
  ident: e_1_3_2_13_1
  article-title: Zearalenone Changes the Diversity and Composition of Caecum Microbiota in Weaned Rabbit
  publication-title: Biomed Res Int
– ident: e_1_3_2_10_1
  doi: 10.1136/annrheumdis-2019-215933
– ident: e_1_3_2_23_1
  doi: 10.3390/nu13072125
– ident: e_1_3_2_26_1
  doi: 10.1111/1751-7915.13769
– ident: e_1_3_2_16_1
  doi: 10.1080/21655979.2021.1933840
– ident: e_1_3_2_17_1
  doi: 10.3389/fphys.2020.524236
– ident: e_1_3_2_15_1
  doi: 10.1371/journal.pone.0230895
– ident: e_1_3_2_21_1
  doi: 10.1016/j.apsb.2019.10.007
SSID ssj0001034578
Score 2.3915315
Snippet Asymptomatic hyperuricemia (AH) is an early stage of gout. Emerging evidence shows that the intestinal microbiota is related to gout. However, the relationship...
SourceID pubmedcentral
proquest
pubmed
crossref
informaworld
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 7263
SubjectTerms 16s rRNA gene
Aged
Asymptomatic Diseases
Asymptomatic hyperuricemia
Bacteria - genetics
diagnostic model
Feces - microbiology
Female
Gastrointestinal Microbiome - genetics
gut microbiota
Humans
Hyperuricemia - epidemiology
Hyperuricemia - microbiology
Male
Middle Aged
Probiotics
Research Paper
Title Gut Microbiota Characterization in Patients with Asymptomatic Hyperuricemia: probiotics increased
URI https://www.tandfonline.com/doi/abs/10.1080/21655979.2021.1976897
https://www.ncbi.nlm.nih.gov/pubmed/34590550
https://www.proquest.com/docview/2578151583
https://pubmed.ncbi.nlm.nih.gov/PMC8806635
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELZ4LDAg3pSXjMSaksSO67BVCKiQihiKBFNkp7aIRNOqSQf-PXdxUloEYmCMnLMsn33-7nz-jpDLNA6MFYx5htuhx630PQl-kKes6YDOtRZVbk7_UfSe-cNL1GQTFnVaJfrQ1hFFVLYaN7fSRZMRdxUGAnEwPjMJg3YAB6qMO6tkPQSgiFl9_mvvK8ziMx5V9hilPBRr3vH81tPSCbXEX_oTCv2eTLlwOt1tk60aVtKuWwc7ZMXku2RzgWxwj6j7WUn7mSNeKhW9mVM1u5eYNMvpk2NZLSiGZ2m3-BhNynFF6kp74LBOKwqiUaau6cR1k6UFyCHyLMxwnwzubgc3Pa8usOClXMjSs4ph7SKFV48MVBNbo7QwXCgjhiKC1tDEGhCS4JH01TBlzAgDkAV8Os4NOyBr-Tg3R4RyayLtpzzWCiCJ4hKQnGax9RnMSyhli_BmTpO0Jh_HGhjvSVBzlDaqSFAVSa2KFmnPxSaOfeMvgXhRYUlZhT2sq1GSsD9kLxrtJrDH8OJE5WY8KxI0awj8JGuRQ6ft-XBgecU-uHkt0llaB_MfkL97uSXP3ioebzCdiPeO_zHmE7KBny4mdErWyunMnAFKKvV5tQ8-Af6qCFk
linkProvider Taylor & Francis
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB5RONAeKh5t2fKokbiGJmvH6_SGUCFQFnFYJDhZTtZWI0F2RbKH_vvOxMmyi6g49OyMZXnG428mM58BjvIksk5yHljhxoFwKgwUxkGBcXaAOs8y2dTmDK9leisu7-K7hV4YKqukGNp5oojGV9PhpmR0VxL3vR9JAsLUZ9KPjiO8UVUyeAdrscJoAm06vE-f8ywhF3HjkEkqILGukedfMy1dUUsEpq_B0JfVlAvX09kGfGxxJTvxhrAJK7bcgg8LbIPbYM5nNRsWnnmpNux0ztXsWzFZUbIbT7NaMcrPspPqz-O0njSsrizFiPWp4SB6LMwPNvXTFHmFcgQ9Kzv-BKOzn6PTNGhfWAhyIVUdOMPp8SJD_x456iZx1mTSCmmsHMsYR_s2yRAiSRGr0Ixzzq20iFkwqBPC8s-wWk5KuwNMOBtnYS6SzCAmMUIhlMt44kKO-9JXqgei21Odt-zj9AjGg45aktJOFZpUoVtV9OB4Ljb19BtvCSSLCtN1k_dw_pESzd-QPey0q_GQ0Z8TU9rJrNLk1wj5Kd6DL17b8-WgeSUhxnk9GCzZwfwDIvBeHimL3w2RN_pOAnxf_2PN32A9HQ2v9NXF9a9deE9DPkG0B6v108zuI2Sqs4PmTPwFQnkLxA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwEB2VIiF6QHyzQIuRuKYka8drc6vabrdAqx6KBCfLSWwRiWZXTfbQf8-MnSy7iKoHzs5Ylp89fuOM3wB8KHXmvOQ8ccJXifAqTRTGQYn1boKYF4UMuTln53L2TXz-ng_ZhG2fVkkxtI9CEcFX0-ZeVH7IiPs4ziTxYHpmMs72MzxQlZ7cg_u50oEjpT9mf65ZUi7y4I_JKiGz4R3PbT1tnFAb-qX_YqF_J1OunU7Tx_Cop5XsIK6DJ7DlmqewsyY2-AzsybJjZ3UUXuosO1xJNceXmKxu2EVUWW0ZXc-yg_bmatHNg6grm2HAeh0kiK5q-4ktYjd12aIdMc_WVc_hcnp8eThL-gILSSmk6hJvOdUusvTrkSM02jtbSCekdbKSObaOnS6QIUmRq9RWJedOOqQsGNMJ4fgL2G7mjXsFTHiXF2kpdGGRklihkMkVXPuU47yMlRqBGObUlL34ONXA-GWyXqN0gMIQFKaHYgT7K7NFVN-4y0CvA2a6cO3hY40Sw--wfT-ga3CP0Y8T27j5sjXk1oj4KT6ClxHt1XBweekUw7wRTDbWweoD0u_ebGnqn0HHG10n8b3X_zHmd_Dg4mhqvp6ef3kDD6klXg-9he3ueul2kTB1xV7YEr8Bhz8K7Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gut+Microbiota+Characterization+in+Patients+with+Asymptomatic+Hyperuricemia%3A+probiotics+increased&rft.jtitle=Bioengineered&rft.au=Yang%2C+Hai-Tao&rft.au=Xiu%2C+Wen-Juan&rft.au=Liu%2C+Jing-Kun&rft.au=Yang%2C+Yi&rft.date=2021-01-01&rft.issn=2165-5987&rft.eissn=2165-5987&rft.volume=12&rft.issue=1&rft.spage=7263&rft_id=info:doi/10.1080%2F21655979.2021.1976897&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2165-5979&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2165-5979&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2165-5979&client=summon